glp 1 cigna Evernorth expands program to help employers curb GLP-1 costs Cigna's Evernorth launches Wegovy, Zepbound

When adding tirzepatide to existing therapy, particularly insulin or sulfonylureas, dose reductions of these agents may be necessary to minimize hypoglycemia risk

In October 2025, an ICC Trial Chamber convicted a senior member of the Janjaweed of numerous crimes in Darfur, Sudan, including, in an important jurisprudential landmark, two counts of crimes against humanity of gender persecution. In November, the ICC will commence perhaps its most consequential trial, that of Duterte, the former Philippine president

Possible Joint Support Some preliminary research suggests cartilage-protective properties

Together MK 677 and Ipamorelin offer a comprehensive approach to study physiological adaptations through growth hormone pathway modulation